Page last updated: 2024-10-22

am 580 and Nasal Polyps

am 580 has been researched along with Nasal Polyps in 1 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Nasal Polyps: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Million, K1
Tournier, F1
Houcine, O1
Ancian, P1
Reichert, U1
Marano, F1

Other Studies

1 other study available for am 580 and Nasal Polyps

ArticleYear
Effects of retinoic acid receptor-selective agonists on human nasal epithelial cell differentiation.
    American journal of respiratory cell and molecular biology, 2001, Volume: 25, Issue:6

    Topics: Benzoates; Biomarkers; Cell Differentiation; Cell Nucleus; Cilia; Epithelial Cells; Gene Expression

2001